Nuvation Bio Inc.
NUVB
$4.39
-$0.11-2.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M |
| Total Depreciation and Amortization | 539.00K | 534.00K | 356.00K | 310.00K | 219.00K |
| Total Amortization of Deferred Charges | 327.00K | 317.00K | 18.00K | -- | -- |
| Total Other Non-Cash Items | 12.27M | 10.71M | 10.26M | 7.54M | 9.67M |
| Change in Net Operating Assets | -6.28M | -8.66M | 194.00K | 2.76M | -6.75M |
| Cash from Operations | -29.73M | -52.89M | -48.18M | -42.63M | -46.30M |
| Capital Expenditure | -89.00K | -12.00K | -181.00K | -72.00K | 13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -92.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.17M | -96.61M | 55.06M | 54.25M | 51.85M |
| Cash from Investing | 87.08M | -96.62M | 54.88M | 54.18M | 51.77M |
| Total Debt Issued | 11.20M | 0.00 | 198.90M | -- | 5.57M |
| Total Debt Repaid | -11.62M | -68.00K | -166.00K | -534.00K | -7.63M |
| Issuance of Common Stock | 8.49M | 558.00K | 1.30M | 1.08M | 1.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 11.00K | -6.61M | -- | -- |
| Cash from Financing | 8.06M | 501.00K | 193.42M | 548.00K | -900.00K |
| Foreign Exchange rate Adjustments | -224.00K | -64.00K | -128.00K | 151.00K | 1.12M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.19M | -149.07M | 199.99M | 12.25M | 5.69M |